The Advanced Human Imaging Ltd (ASX: AHI) share price is having an incredible run this week.
Shares are swapping hands at $1.10 at the time of writing, up 27.5% since the close of trade on Monday.
Advanced Human Imaging is a company developing human scanning technology for smartphones.
What’s the latest?
The Advanced Human Imaging share price was off and racing last week with no new news released.
The company listed on the Nasdaq in November, so let’s take a look at its recent performance on the United States exchange for more perspective.
Shares in the company’s US-listed ticker (NASDAQ: AHI) surged 36.2% on the first trading day of the week in the US to $6.02.
The company has developed patented technology that enables people to check, track and assess health data using a smartphone “via the combining of body dimensions, body composition and vital signs”.
Advanced Human Imaging said it has improved its mobile-device risk assessment, advanced 2D-3D capturing and was now offering real-time personalised health data.
The company will also launch derma scanning on the skin using artificial intelligence at a Las Vegas technology conference in January 2022.
What did management say?
CEO Vlado Bosanac said:
We accelerated the rollout due to the increase we have seen in the telemedicine and telehealth industry due to the COVID-19 pandemic.
We are addressing an immediate need posed by incoming enquiries and new partner opportunities across the health, mHealth and insurance sector.
Advanced Human Imaging share price snapshot
It has been a bumpy ride for the company of late. The Advanced Human Imaging share price has lifted 10% in the past 12 months but is down around 14% this year to date.
In contrast, the benchmark S&P/ASX 200 Index (ASX: XJO) has returned nearly 10% in the past year.